Bioventus Inc.
Bioventus Inc. (BVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BVS · as of Jun 8, 2026
Key Statistics
Explore Bioventus Inc. Data
bvs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 66.7%
The BVS analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +43.81% upside from the current price of $9.04.
Competitors & Peers
bvs competitorsBVS
AVNS
BFLY
CBLL
CTKB
KIDSStock Performance
Full HistoryAbout Bioventus Inc.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and international…
what is bioventus inc. · bvs stock overview · bioventus inc. company profile · who is bioventus inc. ceo · bvs NASDAQ · bioventus inc. headquarters · bioventus inc. business segments
About Stock Overview & Key Data
Bioventus Inc. (BVS) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 11, 2021. As of the latest trading session, BVS stock price is $9.04, with a market capitalization of $612.4M. The stock has returned +34.52% over the past 12 months and +21.51% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Bioventus Inc. stock is Buy, with an average 12-month price target of $13.00. In fiscal year 2025, Bioventus Inc. reported revenue of $568.1M and net income of $22.7M. For detailed data — including Bioventus Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bioventus Inc. (BVS) stock price is $9.04. The stock is traded on NASDAQ under the ticker symbol BVS. The 52-week range is $5.81 – $11.25.